Research
Clinical Research
"The AUDACITY Study (Allurion Device in Adults with Clinical ObesITY): A prospective, open-label, multi-center, randomized, pivotal safety and efficacy study of the Allurion Gastric Balloon System and moderate intensity lifestyle modification therapy program vs. moderate intensity lifestyle modification therapy program for the treatment of adults with obesity."
Principal Investigator: Corrigan McBride, MD
Co-Investigators: Tiffany Tanner, MD; Vishal Kothari, MD; Ivy Haskins, MD; Anthony Murante, MD
Project Manager: Crystal Krause, PhD
Dates: May 1, 2023 to Sept. 30, 2024
Agency: Allurion Technologies Inc.
"Healthy Bones, Healthy Life: Effect of habitual physical activity on bone and metabolic health in pediatric cancer survivors"
Principal Investigator: Melissa Acquazzino, MD
Co-Investigators: Crystal Krause, PhD; Laura Bilek, PhD
Dates: Sept. 1, 2020 to Aug. 31, 2024
Agency: Pediatric Cancer Research Group
Pre-Clinical Research
Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer
Principal Investigator: Aaron Mohs, PhD
Co-Investigator: Mark A. Carlson, MD
Dates: March 4, 2022 to Feb. 28, 2027
Agencies: Department of Health and Human Services, National Institute of Health, National Cancer Institute
Effect of cell-based therapies on functional, hemodynamic, and histologic outcomes in a porcine model of peripheral arterial disease.
Co-Principal Investigators: Mark A. Carlson, MD; Iraklis Pipinos, MD
Dates: Aug. 15, 2019 to March 31, 2025
Agencies: National Institute of Health, National Institute on Aging
Injectable, shape recoverable, and resorbable nanofiber foams for junctional hemorrhage control
Initiating Principal Investigator: Jingwei Xie, PhD
Partnering Principal Investigator: Mark A. Carlson, MD
Dates: Dec. 13, 2019 to April 30, 2024
Agency: DoD Peer Reviewed Medical Research Program
Center for Cardiovascular Research in Biomechanics
Mentors: Mark A. Carlson, MD; Iraklis Pipinos, MD; Jason MacTaggart, MD
Co-Mentor: Jingwei Xie, PhD
Biostatistician: Christopher Wichman, PhD
Dates: Feb. 15, 2024 to Jan. 31, 2029
Agencies: Department of Health and Human Services, National Institute of Health, National Institute of General Medical Sciences